The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

From January 1, 2023 to December 30, 2023, patients who were suspected of pulmonary embolism and underwent CTPA examination at Nanyang Hospital of Southern Medical University were divided into pulmonary embolism group and non pulmonary embolism group. 1. Collect relevant data, including gender, age, primary disease, CTPA imaging and reports, BNP, troponin, electrocardiogram, cardiac ultrasound, PT, APTT, TT, fibrinogen, D-dimer, etc., and analyze demographic data, pulmonary embolism risk grading, APTT/fibrinogen ratio, and determine their cut-off values through statistical analysis of the two groups. 2. Follow up on the APTT/fibrinogen ratio after anticoagulation treatment and bleeding in the pulmonary embolism group.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Voluntary signing of informed consent form;

• When signing the informed consent form, the age is equal to or greater than 18 years old, regardless of gender;

• From January 1, 2023 to December 30, 2023, the patient was diagnosed with suspected pulmonary embolism at the Southern Hospital of Southern Medical University and underwent enhanced pulmonary artery scanning examination.

Locations
Other Locations
China
Nanfang hospital of Southern Medical University
RECRUITING
Guangzhou
Contact Information
Primary
Xintong Huang
1556807596@qq.com
8619355230761
Time Frame
Start Date: 2018-01-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 800
Treatments
Patients with acute pulmonary embolism
Patients without acute pulmonary embolism
Related Therapeutic Areas
Sponsors
Leads: Nanfang Hospital, Southern Medical University

This content was sourced from clinicaltrials.gov